Characterization of aerosol output from various nebulizer/compressor combinations.

OBJECTIVES Different commercially available nebulizers and compressors are available. However, the optimal combination for drug delivery is unknown. METHODS Flow rates of five different compressors (n = 3/compressor) tested alone and in combination with five different commercial nebulizers (n = 9 of each brand of nebulizer) were evaluated. Thereafter, the performances of the different nebulizers were evaluated using 2.5 mg albuterol solution (0.5 mL) added to 2.5 mL saline at flow rates of 2, 3, 4, and 5 L/minute using a laser particle analyzer. Volume median diameter and percentage of particles in the respirable range (1-5 microm) were calculated from this data. Time for nebulization (in seconds) and residual volume (in milliliters) were also recorded. RESULTS The mean flow rates for the compressors evaluated without a nebulizer attached ranged from 6.6 L/minute (LifeCare Freedom-neb; LifeCare International, Lafayette, CO) to 12.2 L/minute (DeVilbiss Pulmo-Aide; DeVilbiss Health Care, Somerset, PA). Flow rates for the nebulizer/compressor combinations ranged from 2.08 L/minute (Pari LC Jet Proneb; Pari Respiratory Equipment, Richmond, VA) to 5.42 L/minute (Puritan Bennett Raindrop; Puritan Bennett, Lenexa, KS/Omron Compare; Omron, Health Care,Vernon Hills, IL). Using the repeated measure ANOVA model, the interaction between flow rate and device was significant (P < 0.001) for both percentage of particles in the respirable range and log volume median diameter. It was observed that the percentage of particles in the respirable range for the Pari LC Jet did not increase across flow rates in contrast to the other 4 nebulizers. All comparisons to the Pari LC Jet at 2 L/minute were significant. CONCLUSIONS Marked variability exists in the flow rates among different commercially available compressors used for home nebulization of inhaled pulmonary medications. Different nebulizer/compressor combinations have markedly different performance characteristics which could result in different efficacy and safety profiles of the medications being administered via these devices. We recommend that this type of information be used as a starting point for selecting different nebulizer/compressor combinations. Further clinical evaluation is warranted.

[1]  C. Fanta,et al.  A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. , 1996, Chest.

[2]  Barbara B. Huff,et al.  PDR : physicians' desk reference , 1953 .

[3]  M. Allen,et al.  Salbutamol output from two jet nebulizers. , 1993, Respiratory Medicine.

[4]  R. V. Lourenço,et al.  Deposition and clearance of 2 micron particles in the tracheobronchial tree of normal subjects--smokers and nonsmokers. , 1971, The Journal of clinical investigation.

[5]  E. Haponik,et al.  Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. , 1992, Chest.

[6]  D. Ikle,et al.  A comparison of commercial jet nebulizers. , 1994, Chest.

[7]  L. Hendeles,et al.  Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation. , 1992, Chest.

[8]  K. Philipson,et al.  Elimination of test particles from the human tracheobronchial tract by voluntary coughing. , 1979, Scandinavian journal of respiratory diseases.

[9]  H. Matthys,et al.  Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked. , 1985, European journal of respiratory diseases. Supplement.

[10]  H. Nelson,et al.  Optimal duration of nebulized albuterol therapy. , 1993, Chest.

[11]  S. Spector,et al.  The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. , 1983, The Journal of allergy and clinical immunology.

[12]  Why nebulise for more than five minutes? , 1989, Archives of disease in childhood.

[13]  J. Bothner,et al.  Delivery of albuterol in a pediatric emergency department , 1996, Pediatric emergency care.

[14]  J. Weber,et al.  Properties of aerosols produced with three nebulizers. , 2015, The American review of respiratory disease.

[15]  P. Barry,et al.  An in vitro analysis of the output of salbutamol from different nebulizers. , 1999, The European respiratory journal.

[16]  K. Chapman,et al.  A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. , 1993, Chest.

[17]  J. Douglas,et al.  Is the flow rate used to drive a jet nebuliser clinically important? , 1985, British medical journal.

[18]  F. Etzler,et al.  Particle Size Analysis: A comparative study of various methods , 1995 .

[19]  M. Svartengren,et al.  Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. , 1995, The European respiratory journal.

[20]  P. Weiner,et al.  Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. , 1999, Chest.

[21]  M. O'Doherty,et al.  DIFFERENCES IN RELATIVE EFFICIENCY OF NEBULISERS FOR PENTAMIDINE ADMINISTRATION , 1988, The Lancet.

[22]  M. Newhouse,et al.  Emergency department management of life-threatening asthma. Are nebulizers obsolete? , 1993, Chest.

[23]  Dolovich Ma.  Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. , 2000 .

[24]  S. Newman,et al.  Lung deposition from four nebulizers. , 1993, Respiratory medicine.

[25]  D. Pavia,et al.  Factors influencing the size distribution of aerosols from jet nebulisers. , 1983, Thorax.

[26]  J. Bateman,et al.  Is driving gas flow rate clinically important for nebulizer therapy? , 1986, British journal of diseases of the chest.

[27]  S. Lakshminarayan,et al.  Efficiency of air compressor-driven nebulizers. , 1985, Chest.

[28]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[29]  D. Hess,et al.  Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. , 1996, Chest.

[30]  C. Camargo,et al.  Consensus statement: aerosols and delivery devices. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[31]  J. G. Douglas,et al.  A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma. , 1986, British journal of diseases of the chest.

[32]  W. Whitlock,et al.  A model for conversion from small volume nebulizer to metered dose inhaler aerosol therapy. , 1992, Chest.

[33]  H. Nelson,et al.  Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. , 1991, Chest.

[34]  D. Hess,et al.  Nebulizers: principles and performance. , 2000, Respiratory care.

[35]  C. Camargo,et al.  Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. , 2000, Respiratory care.

[36]  G F Alvine,et al.  Disposable jet nebulizers. How reliable are they? , 1992, Chest.

[37]  V. Turjanmaa,et al.  Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. , 1998, Chest.

[38]  F. Paloucek,et al.  Metered-Dose Inhalers and Nebulizers in the Acute Setting , 1992, The Annals of pharmacotherapy.

[39]  John Smith,et al.  Mathematical and graphical interpretation of the log-normal law for particle size distribution analysis , 1964 .

[40]  Roger Williams,et al.  Methods and Devices: IMPROVED LIVER-BIOPSY NEEDLE , 1969 .

[41]  D. Bohning,et al.  Tracheobronchial particle deposition and clearance. A study of the effects of cigarette smoking in monozygotic twins. , 1975, Archives of environmental health.

[42]  S. Clarke,et al.  Evaluation of jet nebulisers for use with gentamicin solution. , 1985, Thorax.